Typhim Vi: side effects, ingredients & package insert

Typhim Vi ingredients (FDA package insert, Section 11)

Per-dose composition as stated in the prescribing information; verified 2026-07-09. Click an ingredient for every vaccine that contains it.

Source: FDA package insert. Formulations change — re-verify before clinical use.

Typhim Vi side effects: where the data is

Reported reactions for Typhim Vi and the other typhoid products are compiled on the typhoid vaccine page: pre-licensure trial reactogenicity, VAERS report counts, and international databases (Canada Vigilance, EudraVigilance, Lareb, VigiAccess). Those counts are spontaneous reports with no denominator — a report does not establish that the vaccine caused the event.

• Pre-licensure clinical trial data
• Post-licensure surveillance (VAERS and international)
• Documented adverse events and causality assessment
• Vaccine Injury Table (VICP) — compensable injuries

Typhim Vi lot number lookup

Typhim Vi vs Vivotif

All licensed typhoid vaccine products side by side. Differences in platform, adjuvant and route are the usual reasons one is chosen over another; efficacy and safety comparisons belong to the trial and surveillance sections of the typhoid vaccine page.

Schedule and age range

Licensed ages and the recommended series for typhoid vaccines are on the typhoid vaccine page; how 31 countries schedule it is on typhoid schedule by country. Always confirm the product-specific age range in the current package insert.

Common questions about Typhim Vi

What are the side effects of Typhim Vi?

Common reactions listed in the Typhim Vi package insert are injection-site pain, redness or swelling and short-lived systemic symptoms such as fever, tiredness or irritability. Rarer events and the reported counts from VAERS and international databases are on the typhoid vaccine page; counts are reports, not rates, and do not prove the vaccine caused the event.

What is in Typhim Vi?

Typhim Vi contains Salmonella typhi Vi capsular polysaccharide as antigen; adjuvant: none; it is Phenol. Excipients: Sodium chloride, Sodium phosphate buffer, Water for injection. Amounts per dose are in the table above, taken from Section 11 of the FDA package insert (verified 2026-07-09).

Where is the Typhim Vi package insert?

The FDA-licensed prescribing information for Typhim Vi is published by Sanofi Pasteur and the FDA; the source used for this page is https://www.fda.gov/vaccines-blood-biologics/vaccines/typhim-vi. Formulations change, so re-verify the current insert before clinical use.

How does Typhim Vi compare with Vivotif?

Typhim Vi (Sanofi Pasteur) uses a subunit platform with adjuvant none, given intramuscular; Vivotif (Bavarian Nordic / Emergent) uses live attenuated with adjuvant none. Both are licensed typhoid vaccines; the comparison table above lists every product.